Contribution
KALGENE PHARMACEUTICALS INC.
$174,000.00
FY 2011-12 · 2012-03-23
Summary
To support a firm in the Pharmaceutical and medicine manufacturing (NAICS: 325410) with a research and development project
Department
Program
—
Recipient
Location
Vancouver, British Columbia|Vancouver, Colombie-Britannique, Canada
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
Award spanning more than one fiscal year. Original reporting period: 2012-2013 - 1st quarter
Additional Information (French)
Octroi s'appliquant à plus d'un exercice. Trimestre de divulgation originale: 2012-2013 - 1er trimestre
Agreement Start Date
2012-03-23
Agreement Type
Contribution
Agreement Value
$174,000.00
Amendment Number
0
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Purpose
To support a firm in the Pharmaceutical and medicine manufacturing (NAICS: 325410) with a research and development project
Program Purpose (French)
Pour supporter une compagnie dans le secteur Fabrication de produits pharmaceutiques et de médicaments (SCIAN: 325410) dans un projet de recherche et développment
Recipient City
Vancouver, British Columbia|Vancouver, Colombie-Britannique
Recipient Country
CA
Recipient Legal Name
KALGENE PHARMACEUTICALS INC.
Reference Number
GC-2013-Q1-22929
